Sutro Biopharma (STRO) Enterprise Value Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Enterprise Value Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.37% |
| Sep 30, 2025 | 56.83% |
| Jun 30, 2025 | 45.38% |
| Mar 31, 2025 | 6.96% |
| Dec 31, 2024 | -184.96% |
| Sep 30, 2024 | -235.06% |
| Jun 30, 2024 | -39.91% |
| Mar 31, 2024 | -6.42% |
| Dec 31, 2023 | 63.22% |
| Sep 30, 2023 | 59.67% |
| Jun 30, 2023 | -40.09% |
| Mar 31, 2023 | -277.32% |
| Dec 31, 2022 | -88.08% |
| Sep 30, 2022 | -51.28% |
| Jun 30, 2022 | -109.04% |
| Mar 31, 2022 | 69.74% |
| Dec 31, 2021 | 35.13% |
| Sep 30, 2021 | -32.60% |
| Jun 30, 2021 | 19.90% |
| Mar 31, 2021 | -90.89% |